Johnson & Johnson hit with $417 million verdict in latest baby powder cancer case

A jury here awarded a woman with ovarian cancer $417 million Monday in a case against Johnson & Johnson, the latest hit to the pharmaceutical company in widespread litigation over the alleged harms of its baby powder.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.